Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Transplantation and Cellular Therapy|December 2, 2023
Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin LymphomaYago Nieto, Pinaki Banerjee, Indresh Kaur, et al.
Cancer|July 17, 2015
Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcomaWilliam W Tseng, Shouhao Zhou, Christina A To, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 4, 2020
Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgeryKevin Diao, Juhee Song, Peter F Thall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell TransplantationJeff K Davies, Lisa L Brennan, John R Wingard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2025
Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory LymphomaYago Nieto, Jeremy Ramdial, Benigno Valdez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2015
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell TransplantationStefan O Ciurea, Peter F Thall, Denái R Milton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantationRaymond Wong, Munir Shahjahan, Xuemei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2013
Platinum-based chemotherapy for variant castrate-resistant prostate cancerAna M Aparicio, Andrea L Harzstark, Paul G Corn, et al.
Cancer|December 29, 2015
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcomaScott M Schuetze, J Kyle Wathen, David R Lucas, et al.
Frontiers in Immunology|May 17, 2021
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 PatientsUri Greenbaum, Kimberly Klein, Fernando Martinez, et al.
Pageof 20